It’s taken me a little longer than expected to get around to posting this review of Erin Spineto’s new book “Islands and Insulin“ — but hey, good things take time, right? It’s a different kind of diabetes book from any I’ve encountered so far; it’s a narrative of a huge sailing adventure + the college-age experiences that shaped Erin’s life, with a generous helping of diabetes on the side — rather than the other way…
Read more »
In the not-so-distant future, people with diabetes or parents caring for type 1 kids could have more peace of mind sleeping through the night thanks to a new device Dexcom’s developing.
The California company that makes continuous glucose monitors (CGMs) is creating what it calls the Dexcom Share, a sort of docking station that would allow you to set your Dex G4 Platinum receiver inside a cradle overnight and have it send your diabetes data…
Read more »
By
AmyT on
April 22, 2013
Two weeks ago today for Spring Break I was in gorgeous, palm-studded Santa Barbara, CA. And what does a diabetes technology geek like me do on vacation? Visit the local research clinic, of course!
Lucky for me, the Sansum Diabetes Research Institute in Santa Barbara (home to the legendary Drs. Lois Jovanovic and Howard Zisser) just happened to be running a clinical trial they were calling “Party Study 2.” I am not making this up.…
Read more »
By
WilD on
April 20, 2013
Welcome back! It’s Saturday again, so time to curl up with a cup of tea/coffee and our weekly diabetes advice column, Ask D’Mine! This week, veteran type 1, diabetes author and educator Wil Dubois tackles a question we’ve never heard before about the probability that continuous glucose monitor (CGM) use might lead to cancer (?). He also has some thoughts about how to manage non-diabetes medical professionals when you’re in the hospital… should an emergency situations…
Read more »
By
MikeH on
April 16, 2013
When exactly the Animas Vibe integrated insulin pump and continuous glucose monitor (CGM) hits the U.S. market is now up to the FDA.
Almost two years after the Animas Vibe hit the market in Europe, this Monday Johnson & Johnson submitted the pump to the U.S. regulatory agency. The company publicly announced the submission during their first quarter earnings call early this morning.
Our Diabetes Community has been anxiously awaiting this news since October, when…
Read more »
